| Date Filed | Type | Description |
| 06/06/2023 |
4
| EGLINTON MANNER CARRIE (President & CEO) has filed a Form 4 on ORASURE TECHNOLOGIES INC|
Txns:
| Paid exercise price by delivering 47,211 shares
@ $5.48, valued at
$258.7k
|
|
| 05/22/2023 |
4
| EGLINTON MANNER CARRIE (Director) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Granted 686 shares
@ $0
Granted 1,487 options to buy
@ $156.63, valued at
$232.9k
|
|
| 12/15/2022 |
4
| EGLINTON MANNER CARRIE (Director) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Bought 625 shares
@ $175.02, valued at
$109.4k
|
|
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2020 |
4
| EGLINTON MANNER CARRIE (Director) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Granted 2,794 options to buy
@ $113.78, valued at
$317.9k
|
|
| 06/15/2020 |
3
| EGLINTON MANNER CARRIE (Director) has filed a Form 3 on REPLIGEN CORP |
| 04/28/2020 |
4
| EGLINTON MANNER CARRIE (SVP, Advanced Diagnostics) has filed a Form 4 on QUEST DIAGNOSTICS INC|
Txns:
| Sold 2,500 shares
@ $112.03, valued at
$280.1k
Sold 2,500 shares
@ $110, valued at
$275k
|
|
| 03/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2020 |
4
| EGLINTON MANNER CARRIE (SVP, Advanced Diagnostics) has filed a Form 4 on QUEST DIAGNOSTICS INC|
Txns:
| Paid exercise price by delivering 1,543 shares
@ $106.52, valued at
$164.4k
|
|
| 02/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2019 |
4
| EGLINTON MANNER CARRIE (SVP, Advanced Diagnostics) has filed a Form 4 on QUEST DIAGNOSTICS INC|
Txns:
| Paid exercise price by delivering 1,767 shares
@ $82.27, valued at
$145.4k
|
|
| 02/27/2018 |
4
| EGLINTON MANNER CARRIE (SVP, Advanced Diagnostics) has filed a Form 4 on QUEST DIAGNOSTICS INC|
Txns:
| Paid exercise price by delivering 387 shares
@ $102.69, valued at
$39.7k
|
|
| 02/21/2018 |
4
| EGLINTON MANNER CARRIE (SVP, Advanced Diagnostics) has filed a Form 4 on QUEST DIAGNOSTICS INC|
Txns:
| Granted 3,380 shares
@ $0
Granted 38,623 options to buy
@ $103.57, valued at
$4M
|
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/21/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |